| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMOA033122 |
| P698 | PubMed publication ID | 15254284 |
| P50 | author | Peter Garred | Q59433407 |
| Søren Jacobsen | Q61093861 | ||
| P2093 | author name string | Hans O Madsen | |
| Tommy Øhlenschlaeger | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| thrombosis | Q261327 | ||
| P304 | page(s) | 260-267 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus | |
| P478 | volume | 351 |
| Q36461116 | Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus |
| Q36955395 | Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis |
| Q51129973 | Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. |
| Q39196176 | Anti-endothelial cell antibodies in rheumatic heart disease |
| Q46508618 | Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases). |
| Q24647006 | Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology |
| Q36458127 | Atherogenesis in rheumatology |
| Q61914425 | Chapter 7 Genetic Aspects of the Antiphospholipid Syndrome: Association with Clinical Manifestations |
| Q36196922 | Clinical manifestations of mannan-binding lectin deficiency |
| Q36385166 | Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer |
| Q43540341 | Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis |
| Q36269099 | Complement activation and cardiac surgery: a novel target for improving outcomes |
| Q37030627 | Complement deficiencies and systemic lupus erythematosus |
| Q36572977 | Complement deficiencies in humans and animals: links to autoimmunity |
| Q38210887 | Complement deficiencies in systemic lupus erythematosus |
| Q37853050 | Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome |
| Q30470544 | Deficiency of complement factor MBL in a patient required cardiac surgery after an acute myocardial infarction with underlining chronic lymphocytic leukemia |
| Q30425921 | Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children |
| Q38162490 | Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus |
| Q35940072 | Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus |
| Q43417859 | Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. |
| Q39108752 | Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes |
| Q37578126 | European Forum on Antiphospholipid Antibodies: research in progress |
| Q38310605 | Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth |
| Q35330085 | Extreme high prevalence of a defective mannose-binding lectin (MBL2) genotype in native South American West Andean populations. |
| Q30441472 | Fluorochrome-linked immunoassay for functional analysis of the mannose binding lectin complement pathway to the level of C3 cleavage |
| Q48285121 | Functional mannose binding lectin levels in patients with pediatric onset systemic lupus erythematosus in remission. |
| Q35907216 | Genetic Susceptibility to Sepsis: A Possible Role for Mannose-binding Lectin |
| Q42603120 | Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity |
| Q36807470 | Genetic risk factors for thrombosis in systemic lupus erythematosus |
| Q37439346 | Genetic studies of systemic lupus erythematosus in Asia: where are we now? |
| Q34288248 | Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus |
| Q38128800 | Genetics and epigenetics of systemic lupus erythematosus. |
| Q64041611 | Genetics in systemic lupus erythematosus: entering the borough of cardiovascular risk |
| Q38066385 | Global trends, potential mechanisms and early detection of organ damage in SLE. |
| Q38164341 | If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it? |
| Q38856073 | IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis |
| Q38169834 | Innate immunity in renal transplantation: the role of mannose-binding lectin. |
| Q39018377 | Innate immunity, hemostasis and matrix remodeling: PTX3 as a link |
| Q42956271 | Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus |
| Q37703122 | Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques |
| Q35168656 | Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study |
| Q63728009 | Low mannose-binding lectin serum levels are associated with reduced kidney graft survival |
| Q50561607 | MBL2 gene variants coding for mannose-binding lectin deficiency are associated with increased risk of nephritis in Danish patients with systemic lupus erythematosus. |
| Q36402570 | Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk |
| Q80961602 | Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population |
| Q35638080 | Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus |
| Q36270453 | Mannan-binding-lectin-associated serine proteases, characteristics and disease associations |
| Q43257039 | Mannose binding lectin levels are not related to radiographic damage in ankylosing spondylitis |
| Q36310396 | Mannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic Patients |
| Q28271075 | Mannose-binding lectin and maladies of the bowel and liver |
| Q44807801 | Mannose-binding lectin gene polymorphisms in Brazilian patients with systemic lupus erythematosus. |
| Q34562723 | Mannose-binding lectin in innate immunity: past, present and future |
| Q38505801 | Mannose-binding lectin without the aid of its associated serine proteases alters lipopolysaccharide-mediated cytokine/chemokine secretion from human endothelial cells |
| Q40224083 | Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis |
| Q28267664 | Mannose-binding lectin: biology and clinical implications |
| Q36577507 | Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus |
| Q38125279 | Molecular biology of atherosclerosis |
| Q37718970 | Molecular defects in the mannose binding lectin pathway in dermatological disease: Case report and literature review. |
| Q89947833 | No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus |
| Q52668758 | Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. |
| Q64248332 | Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL) |
| Q36054872 | Optimal care of lupus nephritis patients |
| Q38316662 | Photoprotein aequorin as a novel reporter for SNP genotyping by primer extension-application to the variants of mannose-binding lectin gene |
| Q35309510 | Protective molecules and their cognate antibodies: new players in autoimmunity |
| Q34479998 | Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity |
| Q37104562 | Regional association-based fine-mapping for sodium-lithium countertransport on chromosome 10. |
| Q50803898 | Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. |
| Q54324076 | Serum levels and H/L gene polymorphism of mannose-binding lectin in primary open angle glaucoma. |
| Q55933861 | Systemic lupus erythematosus |
| Q92239487 | The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System |
| Q44205820 | The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk |
| Q37063384 | The role of mannose-binding lectin in systemic lupus erythematosus. |
| Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
| Q37642828 | Thrombosis in systemic lupus erythematosus: risk and protection |
| Q33869527 | Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis. |
Search more.